Bank of Montreal’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,157
| Closed | -$28K | – | 5228 |
|
|
2020
Q3 | $28K | Sell |
2,157
-1,043
| -33% | -$9.91K | ﹤0.01% | 3685 |
|
|
2020
Q2 | $22K | Buy |
3,200
+2,773
| +649% | +$21.2K | ﹤0.01% | 3825 |
|
|
2020
Q1 | $3K | Sell |
427
-4,434
| -91% | -$39.1K | ﹤0.01% | 3824 |
|
|
2019
Q4 | $59K | Buy |
4,861
+815
| +20% | +$8.91K | ﹤0.01% | 3770 |
|
|
2019
Q3 | $47K | Buy |
4,046
+837
| +26% | +$8.81K | ﹤0.01% | 3658 |
|
|
2019
Q2 | $32K | Buy |
3,209
+2,180
| +212% | +$23.5K | ﹤0.01% | 3909 |
|
|
2019
Q1 | $13K | Sell |
1,029
-1,841
| -64% | -$27.4K | ﹤0.01% | 3808 |
|
|
2018
Q4 | $43K | Sell |
2,870
-143
| -5% | -$2.73K | ﹤0.01% | 3343 |
|
|
2018
Q3 | $60K | Sell |
3,013
-7
| -0.2% | -$159 | ﹤0.01% | 3314 |
|
|
2018
Q2 | $59K | Buy |
3,020
+244
| +9% | +$5.4K | ﹤0.01% | 3351 |
|
|
2018
Q1 | $55K | Sell |
2,776
-628
| -18% | -$10.6K | ﹤0.01% | 3210 |
|
|
2017
Q4 | $46K | Sell |
3,404
-139,384
| -98% | -$2.1M | ﹤0.01% | 3293 |
|
|
2017
Q3 | $2.63M | Buy |
142,788
+26,736
| +23% | +$498K | ﹤0.01% | 1478 |
|
|
2017
Q2 | $2.13M | Buy |
116,052
+49,560
| +75% | +$982K | ﹤0.01% | 1586 |
|
|
2017
Q1 | $1.5M | Buy |
66,492
+64,898
| +4,071% | +$1.55M | ﹤0.01% | 1676 |
|
|
2016
Q4 | $53K | Sell |
1,594
-50,214
| -97% | -$1.5M | ﹤0.01% | 3092 |
|
|
2016
Q3 | $1.27M | Sell |
51,808
-7,626
| -13% | -$191K | ﹤0.01% | 1713 |
|
|
2016
Q2 | $1.42M | Sell |
59,434
-9,134
| -13% | -$209K | ﹤0.01% | 1666 |
|
|
2016
Q1 | $1.6M | Sell |
68,568
-7,213
| -10% | -$171K | ﹤0.01% | 1540 |
|
|
2015
Q4 | $2.29M | Buy |
75,781
+73,152
| +2,783% | +$2.36M | ﹤0.01% | 1344 |
|
|
2015
Q3 | $104K | Buy |
2,629
+1,137
| +76% | +$70.6K | ﹤0.01% | 2605 |
|
|
2015
Q2 | $103K | Sell |
1,492
-417,172
| -100% | -$26.2M | ﹤0.01% | 2737 |
|
|
2015
Q1 | $22.9M | Sell |
418,664
-513,927
| -55% | -$24.5M | 0.03% | 457 |
|
|
2014
Q4 | $39.7M | Sell |
932,591
-240,100
| -20% | -$8.68M | 0.05% | 316 |
|
|
2014
Q3 | $37.4M | Sell |
1,172,691
-826,940
| -41% | -$17.6M | 0.04% | 341 |
|
|
2014
Q2 | $41.4M | Buy |
1,999,631
+290,702
| +17% | +$5.37M | 0.05% | 298 |
|
|
2014
Q1 | $33.1M | Buy |
1,708,929
+1,695,997
| +13,115% | +$36M | 0.04% | 301 |
|
|
2013
Q4 | $314K | Buy |
12,932
+759
| +6% | +$17.9K | ﹤0.01% | 2038 |
|
|
2013
Q3 | $261K | Hold |
12,173
| – | – | ﹤0.01% | 2116 |
|
|
2013
Q2 | $271K | Buy |
+12,173
| New | +$268K | ﹤0.01% | 2037 |
|
Bank of Montreal's AMAG Position: Q4 2020 in Review
Bank of Montreal sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,157 shares — an estimated $28K sold.
Bank of Montreal first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $41.4M in Q2 2014. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Bank of Montreal reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Bank of Montreal sold 2,157 AMAG Pharmaceuticals shares in Q4 2020, an estimated $28K.
- Bank of Montreal first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Bank of Montreal's AMAG Pharmaceuticals position peaked at $41.4M in Q2 2014.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.